Literature DB >> 20307033

Assessing the reliability of automated OCT retinal thickness measurements in patients with choroidal neovascularization due to age-related macular degeneration.

Mehran Taban1, Dawn Williams, Scott D Smith, Peter K Kaiser.   

Abstract

BACKGROUND AND
OBJECTIVE: To compare automated versus manual retinal measurement using Stratus optical coherence tomography (OCT) (Carl Zeiss Meditec, Dublin, CA) in patients with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). PATIENTS AND METHODS: Patients with subfoveal CNV due to AMD underwent Stratus OCT imaging. Each scan was evaluated for automated: foveal center point thickness, central subfield thickness, signal strength, and manual: central retinal thickness, central retinal/lesion thickness, CNV thickness, pigment epithelial detachment thickness, and number of correct retinal boundaries (CRBs).
RESULTS: A total of 209 OCT visits (49 patients) were assessed. On fast macular thickness map, 52% of scans had less than 4 (of possible 6) CRBs placed by the automated OCT algorithm. There was a mean difference of 34 microm between automated foveal center point thickness and manual central retinal thickness (P < .00005). Only 40% and 27% of automated foveal center point thickness and central subfield, respectively, lay within +/- 25 microm of manual central retinal thickness. As the number of CRBs or signal strength increased, the difference between manual and automated measurements decreased.
CONCLUSION: Manual retinal thickness measurements differ significantly from those calculated by the current automated Stratus OCT software in exudative AMD. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20307033     DOI: 10.3928/15428877-20100303-03

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  1 in total

1.  Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome.

Authors:  Heinrich Gerding; Vlassios Loukopoulos; Juliane Riese; Lars Hefner; Melanie Timmermann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-09       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.